PMC6260726_01
T2W screening images of uterine fibroids (red asterisks) in a) the sagittal and b) axial plane
40349_2018_116_Fig3_HTML.jpg
PMC6260726_01_40349_2018_116_Fig3_HTML.jpg
Fig3
Funaki type I based on T2W images, and contrast-enhanced T1W images were assessed. Fibroid sizes were 5.0 x 4.6 x 4.8 cm3, 2.5 x 1.3 x 2.0 cm3, and 2.8 x 1.9 x 2.4 cm3 (Fig. 3).  
T2W planning images displayed on the therapy planning console with ultrasound beam view where bowels are presented with red color and target uterine fibroid not accessible with blue color
40349_2018_116_Fig4_HTML.jpg
PMC6260726_01_40349_2018_116_Fig4_HTML.jpg
Fig4
T2W planning images displayed on the therapy planning console with ultrasound beam view after application of wedged gel pad where red color boundary is bowels, blue is uterine fibroid, and green is the gel pad
40349_2018_116_Fig5_HTML.jpg
PMC6260726_01_40349_2018_116_Fig5_HTML.jpg
Fig5
Contrast enhanced T1W images immediately after the treatment (NPVs: 86% and 39%) and at 3-month follow-up (Shrinkages: 49% and 2.5%)
40349_2018_116_Fig6_HTML.jpg
PMC6260726_01_40349_2018_116_Fig6_HTML.jpg
Fig6
T1W images were acquired, indicating non-perfused volume ratios (NPVs) of 86% and 39% (Fig. 6). There were no areas of abnormal enhancement within the subcutaneous tissue, and skin was normal after treatment. The volume and shrinkage of the fibroids at 3 months follow-up were 29 mL and 49%, 5 mL and 2.5% respectively (Fig. 6).
PMC6260726_02
T2W screening images of uterine fibroid (red asterisk) in a) the sagittal and b) axial plane
40349_2018_116_Fig7_HTML.jpg
PMC6260726_02_40349_2018_116_Fig7_HTML.jpg
Fig7
Funaki type II based on T2W images, and contrast-enhanced T1W images were assessed. Fibroid size was 5.7 x 5.0 x 5.0 cm3 (Fig. 7).  
T2W planning images displayed on the therapy console with ultrasound beam view where bowels are presented with red boundary and uterine fibroid with blue boundary
40349_2018_116_Fig8_HTML.jpg
PMC6260726_02_40349_2018_116_Fig8_HTML.jpg
Fig8
T2W planning images displayed on the therapy console with ultrasound beam view after application of wedged gel pad where red boundary is bowel, blue is uterine fibroid and green is the gel pad
40349_2018_116_Fig9_HTML.jpg
PMC6260726_02_40349_2018_116_Fig9_HTML.jpg
Fig9
Contrast enhanced T1W images in a) sagittal and b) axial plane immediately after the treatment (NPV: 3%)
40349_2018_116_Fig10_HTML.jpg
PMC6260726_02_40349_2018_116_Fig10_HTML.jpg
Fig10
Immediately after the treatment, contrast enhanced T1W images were acquired, showing non-perfused volume ratio (NPV) of only 3% (Fig. 10).